As a board member and co-founder, I am writing today to share some exciting updates about The Happy Lungs Project and our path forward.
Over the past year, we have been working on a strategic work plan in service to our mission.
With involvement and input from key stakeholders, and thanks to the leadership of our board and support from Lilly, I am delighted to share our new mission statement:
To save the lives of RET-positive lung cancer patients by advancing research and treatment options
In pursuit of our mission, our goals are to: